Barclays’s ProQR Therapeutics PRQR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-22,600
| Closed | -$20K | – | 4868 |
|
2022
Q1 | $20K | Buy |
22,600
+22,580
| +112,900% | +$20K | ﹤0.01% | 4331 |
|
2021
Q4 | $0 | Sell |
20
-3
| -13% | – | ﹤0.01% | 3696 |
|
2021
Q3 | $0 | Sell |
23
-12
| -34% | – | ﹤0.01% | 4092 |
|
2021
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 4190 |
|
2021
Q1 | $0 | Sell |
35
-3,153
| -99% | – | ﹤0.01% | 3946 |
|
2020
Q4 | $13K | Sell |
3,188
-5,800
| -65% | -$23.7K | ﹤0.01% | 3424 |
|
2020
Q3 | $43K | Sell |
8,988
-1,500
| -14% | -$7.18K | ﹤0.01% | 3339 |
|
2020
Q2 | $64K | Buy |
10,488
+7,135
| +213% | +$43.5K | ﹤0.01% | 3316 |
|
2020
Q1 | $18K | Buy |
3,353
+3,003
| +858% | +$16.1K | ﹤0.01% | 3401 |
|
2019
Q4 | $4K | Sell |
350
-1,937
| -85% | -$22.1K | ﹤0.01% | 3767 |
|
2019
Q3 | $12K | Buy |
2,287
+204
| +10% | +$1.07K | ﹤0.01% | 3890 |
|
2019
Q2 | $18K | Sell |
2,083
-15,370
| -88% | -$133K | ﹤0.01% | 3979 |
|
2019
Q1 | $243K | Buy |
17,453
+14,237
| +443% | +$198K | ﹤0.01% | 2947 |
|
2018
Q4 | $51K | Buy |
+3,216
| New | +$51K | ﹤0.01% | 3170 |
|